Immune pathogenesis of hepatocellular carcinoma

被引:281
|
作者
Nakamoto, Y [1 ]
Guidotti, LG [1 ]
Kuhlen, CV [1 ]
Fowler, P [1 ]
Chisari, FV [1 ]
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, Div Expt Pathol, La Jolla, CA 92037 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1998年 / 188卷 / 02期
关键词
cytotoxic T lymphocytes; hepatitis B virus; chronic hepatitis; hepatocellular carcinoma; transgenic mice;
D O I
10.1084/jem.188.2.341
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatocellular carcinoma (HCC) is a common complication of chronic hepatitis B virus (HBV) infection. The pathogenetic mechanisms potentially responsible for HCC during chronic HBV infection are not well defined. This study demonstrates that chronic immune-mediated liver cell injury triggers the development of HCC in the absence of viral transactivation, insertional mutagenesis, and genotoxic chemicals. These results strongly suggest that the immune response to HBV is both necessary and sufficient to cause liver cancer during chronic HBV infection, and that all other procarcinogenic events associated with HCC are probably dependent on this process.
引用
收藏
页码:341 / 350
页数:10
相关论文
共 50 条
  • [41] Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis
    Gomaa, Asmaa Ibrahim
    Khan, Shahid A.
    Toledano, Mireille B.
    Waked, Imam
    Taylor-Robinson, Simon D.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (27) : 4300 - 4308
  • [42] The Molecular Pathogenesis and Clinical Implications of Hepatocellular Carcinoma
    Meguro, Makoto
    Mizuguchi, Toru
    Kawamoto, Masaki
    Hirata, Koichi
    INTERNATIONAL JOURNAL OF HEPATOLOGY, 2011, 2011
  • [43] Molecular Pathogenesis and Targeted Therapy of Hepatocellular Carcinoma
    Zender, Lars
    Kubicka, Stefan
    ONKOLOGIE, 2008, 31 (10): : 550 - 555
  • [44] Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances
    Cucarull, Blanca
    Tutusaus, Anna
    Rider, Patricia
    Hernaez-Alsina, Tania
    Cuno, Carlos
    Garcia de Frutos, Pablo
    Colell, Anna
    Mari, Montserrat
    Morales, Albert
    CANCERS, 2022, 14 (03)
  • [45] Another key molecule for pathogenesis of hepatocellular carcinoma
    Tada, Motohisa
    Omata, Masao
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (12) : 1803 - 1804
  • [46] The Role of Oncogenic Viruses in the Pathogenesis of Hepatocellular Carcinoma
    Zemel, Romy
    Issachar, Assaf
    Tur-Kaspa, Ran
    CLINICS IN LIVER DISEASE, 2011, 15 (02) : 261 - +
  • [47] Molecular pathogenesis and systemic therapies for hepatocellular carcinoma
    Llovet, Josep M.
    Pinyol, Roser
    Kelley, Robin K.
    El-Khoueiry, Anthony
    Reeves, Helen L.
    Wang, Xin Wei
    Gores, Gregory J.
    Villanueva, Augusto
    NATURE CANCER, 2022, 3 (04) : 386 - 401
  • [48] Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy
    Kouroumalis, Elias
    Tsomidis, Ioannis
    Voumvouraki, Argyro
    BIOMEDICINES, 2023, 11 (04)
  • [49] Molecular pathogenesis and systemic therapies for hepatocellular carcinoma
    Josep M. Llovet
    Roser Pinyol
    Robin K. Kelley
    Anthony El-Khoueiry
    Helen L. Reeves
    Xin Wei Wang
    Gregory J. Gores
    Augusto Villanueva
    Nature Cancer, 2022, 3 : 386 - 401
  • [50] Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
    Hernandez-Gea, Virginia
    Toffanin, Sara
    Friedman, Scott L.
    Llovet, Josep M.
    GASTROENTEROLOGY, 2013, 144 (03) : 512 - 527